Intraday Performance and Price Movement
The stock of Blue Jet Healthcare Ltd, operating within the Pharmaceuticals & Biotechnology sector, recorded a sharp intraday low of Rs 402.75 on 13 Feb 2026, marking an 8.8% drop from its previous close. This decline contributed to a day change of -9.04%, underperforming its sector by 6.87%. The stock has now declined for two consecutive sessions, accumulating a negative return of approximately 9.01% over this period.
Notably, the stock is trading just 2.42% above its 52-week low of Rs 393, signalling proximity to its lowest levels in the past year. This proximity to the 52-week low underscores the persistent downward momentum affecting the share price.
Technical Indicators and Moving Averages
Blue Jet Healthcare Ltd is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning indicates a bearish trend and suggests that short-term and long-term price momentum remain subdued. The consistent trading below these averages often reflects investor caution and a lack of upward price catalysts.
Sector and Market Context
The Pharmaceuticals & Biotechnology sector, particularly the Medical Equipment/Supplies/Accessories segment, has also experienced downward pressure, with the sector falling by 2.29% on the same day. Blue Jet Healthcare Ltd’s sharper decline relative to its sector highlights company-specific pressures or sentiment factors exacerbating the stock’s weakness.
On the broader market front, the Sensex opened 772.19 points lower and was trading at 82,815.38, down 1.03% on the day. Despite this decline, the Sensex remains 4.04% below its 52-week high of 86,159.02. The index is trading below its 50-day moving average, although the 50DMA remains above the 200DMA, indicating some underlying resilience in the broader market despite short-term weakness.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Relative Performance Over Various Timeframes
Blue Jet Healthcare Ltd’s recent performance contrasts sharply with the broader market. Over the past day, the stock declined by 9.26%, compared to the Sensex’s 1.08% fall. Over one week, the stock fell 2.48% while the Sensex dropped 0.97%. The divergence is more pronounced over longer periods: a 19.77% decline over one month versus a 1.02% Sensex drop, and a 31.01% fall over three months compared to the Sensex’s 2.02% decrease.
Year-to-date, Blue Jet Healthcare Ltd has lost 24.39%, significantly underperforming the Sensex’s 2.87% decline. Over the past year, the stock’s return stands at -47.44%, while the Sensex has gained 8.71%. The stock’s three, five, and ten-year returns remain at zero, indicating no appreciable gains over these extended periods, in stark contrast to the Sensex’s robust gains of 36.97%, 60.59%, and 260.10% respectively.
Mojo Score and Rating Update
Blue Jet Healthcare Ltd currently holds a Mojo Score of 46.0, categorised as a Sell rating. This represents a downgrade from its previous Hold rating, which was revised on 6 Jan 2026. The company’s Market Cap Grade stands at 3, reflecting its mid-tier market capitalisation status within the Pharmaceuticals & Biotechnology sector. The downgrade and low Mojo Score align with the stock’s recent price weakness and technical underperformance.
Market Sentiment and Immediate Pressures
The stock’s sharp intraday decline and sustained weakness over recent sessions suggest prevailing negative sentiment among market participants. The broader market’s modest decline and sectoral underperformance have compounded the pressure on Blue Jet Healthcare Ltd. Trading below all major moving averages further reinforces the cautious stance adopted by investors.
Given the stock’s proximity to its 52-week low and its underperformance relative to both sector and benchmark indices, the immediate price pressure appears to be driven by a combination of technical factors and subdued market sentiment within the Pharmaceuticals & Biotechnology space.
Holding Blue Jet Healthcare Ltd from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Price and Performance Metrics
To summarise, Blue Jet Healthcare Ltd’s stock price has been under sustained pressure, touching an intraday low of Rs 402.75 on 13 Feb 2026, down 8.8% on the day. The stock’s performance continues to lag behind both its sector and the broader market indices, with a notable decline over multiple time horizons. The downgrade in Mojo Grade to Sell and the low Mojo Score of 46.0 reflect the current market assessment of the stock’s outlook.
Trading below all key moving averages and near its 52-week low, the stock remains in a technically weak position. The Pharmaceuticals & Biotechnology sector’s own decline, coupled with a negative market environment as indicated by the Sensex’s fall, has contributed to the immediate price pressures faced by Blue Jet Healthcare Ltd.
Investors monitoring the stock will note the significant divergence from benchmark indices and the absence of upward momentum in recent trading sessions, underscoring the challenges faced in the current market climate.
Unlock special upgrade rates for a limited period. Start Saving Now →
